In a report released today, Daniel Stauder from JMP Securities reiterated a Buy rating on Atricure (ATRC – Research Report), with a price ...

JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on KalVista Pharmaceuticals (KALV – Research Report) today and set a price ...

Paylocity (NASDAQ:PCTY – Free Report) had its target price hoisted by JMP Securities from $250.00 to $270.00 in a research ...

JMP Securities reiterated their market outperform rating on shares of Blue Owl Capital (NYSE:OWL – Free Report) in a research ...

Three British nationals detained in Bali on drug smuggling charges have begun meeting with their legal team as they face the ...

JMP Securities sustained their Market Outperform rating for Independence Realty Trust (NYSE:IRT) with a $22.00 price target. According to InvestingPro data, the stock is currently trading near Fair ...

JMP Securities adjusted its price target for Esperion Therapeutics (NASDAQ:ESPR) shares, lowering it to $4.00 from the previous $7.00. Currently trading at $1.86, the stock sits well below analyst ...

One sportsbook called Eagles' win over the Chiefs "one of the best single-game results in company history" while another book ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...